All
Individualized assessment offers insight to patient's risk exposure to disease
July 1st 2003In the March/April issue of the Journal of the American Animal Hospital Association (AAHA), an Executive Summary of the 2003 Canine Vaccine Guidelines was published. A full text of the guidelines, recommendations, and supporting literature is available to AAHA members on the organization's Web site (www.aahanet.org).
Developing individualized vaccine protocols for your practice
July 1st 2003Developing vaccination protocols for cats and dogs used to seem like an exercise in futility. But now that the American Animal Hospital Association (AAHA) and the American Veterinary Medical Association (AVMA) have each published vaccination guidelines for these species the exercise has become more rewarding because practitioners can now use this information as a benchmark to tailor a specific program for each patient.
Schering-Plough gets Zubrin approval for osteoarthritis in dogs
July 1st 2003Schering-Plough Animal Health Corp. has received approval by the U.S. Food and Drug Administration (FDA) for Zubrin? (tepoxalin) rapidly-disintegrating tablets for the control of pain and inflammation associated with osteoarthritis in dogs.
Addison Biological Laboratories rolls out injectable sterilant for use in male puppies
July 1st 2003The U.S. Food and Drug Administration approved Neutersol? (zinc gluconate neutralized by arginine) as the first injectable neutering drug for puppies 3 to 10 months of age. Addison Biological Laboratory, Inc. will market the product in the United States.
Industry questions AAHA vaccine guidelines; minor changes made
June 1st 2003Cleveland-Just months after the release of the new canine vaccine guidelines, the American Animal Hospital Association (AAHA) has agreed to make two minor revisions and continues to stand behind its recommendations despite some criticism from practitioners and industry.